Insecticides India Ltd

Insecticides India Ltd

₹ 736 -3.86%
29 May - close price
About

Insecticides India is into manufacturing of agrochemicals (technicals and formulations) and biological and household products. They cater to Indian market where they directly sell to the end consumer and also sell technicals and formulations to the companies who are in the business of formulation. They also export to 30 countries with more than 100 customers through registrations. IIL has more than 75 registrations so far.[1]

Key Points

Product Offerings
The company is one of India’s leading crop protection and Nutrition companies, with a portfolio of 20+ technical products and 125 formulation products, including Insecticides, Herbicides, Fungicides, and Biological and PGR products, under brands like Tractor, Green Label, Pulsor, Hakama, and others. Its premium portfolio includes 11 Focused Maharatna products and 33 Maharatna under brands like Hercules, Lethal, Hachiman, Shinwa, etc. [1] [2] [3] [4]

  • Market Cap 2,140 Cr.
  • Current Price 736
  • High / Low 1,098 / 519
  • Stock P/E 15.4
  • Book Value 419
  • Dividend Yield 0.27 %
  • ROCE 15.9 %
  • ROE 12.1 %
  • Face Value 10.0

Pros

Cons

  • The company has delivered a poor sales growth of 8.55% over past five years.
  • Company has a low return on equity of 12.1% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
302 640 696 358 272 657 627 358 359 691 638 385 426
331 594 614 332 264 585 538 327 330 607 548 358 401
Operating Profit -29 46 82 26 9 72 90 31 28 85 89 27 25
OPM % -9% 7% 12% 7% 3% 11% 14% 9% 8% 12% 14% 7% 6%
0 4 0 1 5 3 2 0 3 4 3 1 5
Interest 4 3 3 3 2 2 2 1 2 4 4 5 4
Depreciation 7 7 7 7 8 7 7 8 7 7 9 9 9
Profit before tax -39 40 72 17 4 66 82 22 22 77 79 14 16
Tax % -25% 26% 26% 28% -106% 25% 25% 22% 37% 25% 25% 27% 27%
-29 29 53 12 8 49 61 17 14 58 59 10 12
EPS in Rs -9.90 9.85 17.96 4.16 2.62 16.68 21.13 5.97 4.77 19.97 20.31 3.61 4.02
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
893 906 994 1,073 1,194 1,363 1,420 1,504 1,801 1,966 2,000 2,140
782 814 882 925 1,006 1,207 1,268 1,333 1,679 1,804 1,779 1,913
Operating Profit 111 92 112 148 188 156 153 171 122 162 221 227
OPM % 12% 10% 11% 14% 16% 11% 11% 11% 7% 8% 11% 11%
0 0 7 3 1 3 -2 3 1 10 8 12
Interest 33 26 20 16 15 24 7 7 13 11 7 17
Depreciation 15 16 16 17 20 24 25 26 26 29 29 36
Profit before tax 64 50 82 118 153 111 120 141 84 132 193 187
Tax % 14% 21% 27% 29% 20% 22% 21% 24% 25% 23% 26% 25%
55 40 60 84 123 87 94 107 63 102 142 139
EPS in Rs 19.24 12.77 19.26 27.19 39.62 28.04 30.29 36.29 21.36 34.49 48.81 47.91
Dividend Payout % 0% 10% 7% 5% 3% 10% 4% 6% 14% 9% 4% 0%
Compounded Sales Growth
10 Years: 9%
5 Years: 9%
3 Years: 6%
TTM: 7%
Compounded Profit Growth
10 Years: 13%
5 Years: 7%
3 Years: 30%
TTM: -2%
Stock Price CAGR
10 Years: 10%
5 Years: 16%
3 Years: 18%
1 Year: -14%
Return on Equity
10 Years: 13%
5 Years: 11%
3 Years: 12%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 13 21 21 21 21 21 21 20 30 30 29 29
Reserves 278 388 444 527 641 711 800 850 889 982 1,056 1,191
322 206 237 114 305 191 100 54 163 87 105 157
308 321 277 338 388 372 505 473 615 620 709 623
Total Liabilities 920 936 978 1,000 1,356 1,294 1,426 1,396 1,696 1,719 1,898 2,000
210 198 185 232 240 239 239 253 263 286 282 381
CWIP 38 51 58 17 19 39 59 91 123 142 161 119
Investments 3 3 11 17 12 12 14 16 17 23 29 29
670 684 725 735 1,084 1,004 1,115 1,037 1,294 1,268 1,426 1,472
Total Assets 920 936 978 1,000 1,356 1,294 1,426 1,396 1,696 1,719 1,898 2,000

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-6 86 4 182 -133 242 155 135 -11 187 93
-34 -19 -14 -26 -49 -24 -113 9 -86 -46 -38
36 -64 9 -143 172 -159 -104 -115 80 -98 -61
Net Cash Flow -4 4 -0 13 -11 59 -61 30 -17 42 -5
Free Cash Flow -40 67 -10 154 -171 213 108 68 -97 143 59
CFO/OP 1% 108% 19% 140% -54% 175% 120% 103% 16% 124% 61%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 68 84 78 80 75 86 65 70 60 55 70 83
Inventory Days 220 190 232 214 355 202 248 228 247 221 268 194
Days Payable 118 114 108 128 141 96 136 117 128 115 154 109
Cash Conversion Cycle 170 159 201 166 289 192 177 181 178 161 185 168
Working Capital Days 40 75 80 93 116 98 108 111 92 97 106 106
ROCE % 12% 16% 20% 21% 14% 15% 16% 10% 13% 17% 16%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Dec 2025
Distributor Network (Dealers/Distributors)
Number

Log in to view insights

Please log in to see hidden values.

Login
Product Formulations in Portfolio
Number ・Standalone data
Retailer Reach
Number
Active Technical Products
Number ・Standalone data
Installed Capacity - Granules
MTPA ・Standalone data
Installed Capacity - Technical / Active Ingredients
MTPA ・Standalone data
Total Granted Patents
Number ・Standalone data
Farmer Reach
Millions
Installed Capacity - Liquid Formulations
KLPA ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
72.16% 72.16% 72.16% 72.16% 72.16% 72.16% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30%
6.02% 5.19% 4.41% 4.31% 4.36% 5.43% 5.13% 4.50% 4.65% 4.51% 4.46% 4.50%
10.53% 9.36% 9.12% 9.14% 9.08% 9.06% 9.24% 9.59% 9.72% 9.50% 9.40% 9.27%
11.30% 13.31% 14.32% 14.40% 14.41% 13.36% 13.34% 13.63% 13.32% 13.69% 13.85% 13.94%
No. of Shareholders 18,01218,86818,23219,25219,47422,48422,84922,68821,43622,33622,35922,274

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls